Literature DB >> 28294477

Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.

Kingo Sawada1, Akiko Kanehara1, Eisuke Sakakibara1, Satoshi Eguchi2, Mariko Tada1, Yoshihiro Satomura1, Motomu Suga3, Shinsuke Koike1,4,5, Kiyoto Kasai1.   

Abstract

AIM: There is an increasing need for identifying neurocognitive predictors of global functional outcome in early psychosis toward optimizing an early intervention strategy.
METHODS: We conducted a longitudinal observational study to investigate an association between neurocognitive assessments at baseline and global functional outcome at an average of 1-year follow up. Participants included ultra-high-risk for psychosis (UHR) individuals who had not converted to psychosis during the follow-up period (UHR-NP) and those with first-episode psychosis (FEP). We evaluated neurocognition at baseline using the Brief Assessment of Cognition in Schizophrenia Japanese version, including Verbal Memory, Working Memory, Motor Speed, Verbal Fluency, Attention/Processing Speed, and Executive Function. We also assessed global functional outcome using the modified Global Assessment of Functioning (mGAF) scale both at baseline and after the follow-up period.
RESULTS: Thirty-four UHR-NP individuals (34/47, 72%) and 29 FEP individuals (29/36, 81%) completed assessment of neurocognitive function at baseline and functional outcome at follow up. In the UHR-NP group, Attention/Processing Speed was significantly associated with the mGAF score at follow up. In the FEP group, Executive Function was significantly associated with the average mGAF score during follow up.
CONCLUSION: Attention/Processing Speed and Executive Function at baseline may predict global functional outcome of early psychosis. These neurocognitive tests are easy to incorporate in clinical settings and, if replicated in independent samples, may be included in routine clinical assessments for prediction of functional outcome in early psychosis.
© 2017 The Authors. Psychiatry and Clinical Neurosciences © 2017 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  first-episode psychosis; functional outcome; neurocognitive; predictive biomarker; ultra-high-risk for psychosis

Mesh:

Year:  2017        PMID: 28294477     DOI: 10.1111/pcn.12522

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  13 in total

1.  Detecting motor slowing in clinical high risk for psychosis in a computerized finger tapping model.

Authors:  Katherine S F Damme; K Juston Osborne; James M Gold; Vijay A Mittal
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-08-20       Impact factor: 5.270

2.  Mismatch Negativity Predicts Remission and Neurocognitive Function in Individuals at Ultra-High Risk for Psychosis.

Authors:  Mao Fujioka; Kenji Kirihara; Daisuke Koshiyama; Mariko Tada; Tatsuya Nagai; Kaori Usui; Susumu Morita; Shintaro Kawakami; Kentaro Morita; Yoshihiro Satomura; Shinsuke Koike; Motomu Suga; Tsuyoshi Araki; Kiyoto Kasai
Journal:  Front Psychiatry       Date:  2020-08-03       Impact factor: 4.157

3.  Olfactory deficits in individuals at risk for psychosis and patients with schizophrenia: relationship with socio-cognitive functions and symptom severity.

Authors:  Tsutomu Takahashi; Mihoko Nakamura; Daiki Sasabayashi; Yuko Komori; Yuko Higuchi; Yumiko Nishikawa; Shimako Nishiyama; Hiroko Itoh; Yuri Masaoka; Michio Suzuki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-10-25       Impact factor: 5.270

4.  Functional near-infrared spectroscopy (fNIRS) as a tool to assist the diagnosis of major psychiatric disorders in a Chinese population.

Authors:  YanYan Wei; Qi Chen; Adrian Curtin; Li Tu; Xiaochen Tang; YingYing Tang; LiHua Xu; ZhenYing Qian; Jie Zhou; ChaoZhe Zhu; TianHong Zhang; JiJun Wang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-04-11       Impact factor: 5.270

5.  Reduced cortical thickness of the paracentral lobule in at-risk mental state individuals with poor 1-year functional outcomes.

Authors:  Daiki Sasabayashi; Yoichiro Takayanagi; Tsutomu Takahashi; Shimako Nishiyama; Yuko Mizukami; Naoyuki Katagiri; Naohisa Tsujino; Takahiro Nemoto; Atsushi Sakuma; Masahiro Katsura; Noriyuki Ohmuro; Naohiro Okada; Mariko Tada; Motomu Suga; Norihide Maikusa; Shinsuke Koike; Atsushi Furuichi; Mikio Kido; Kyo Noguchi; Hidenori Yamasue; Kazunori Matsumoto; Masafumi Mizuno; Kiyoto Kasai; Michio Suzuki
Journal:  Transl Psychiatry       Date:  2021-07-14       Impact factor: 6.222

Review 6.  Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms.

Authors:  Mei-Chi Hsu; Yung-Sheng Huang; Wen-Chen Ouyang
Journal:  Lipids Health Dis       Date:  2020-07-03       Impact factor: 3.876

Review 7.  Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs.

Authors:  Kazutaka Ohi; Chika Sumiyoshi; Haruo Fujino; Yuka Yasuda; Hidenaga Yamamori; Michiko Fujimoto; Tomoko Shiino; Tomiki Sumiyoshi; Ryota Hashimoto
Journal:  Int J Mol Sci       Date:  2018-11-30       Impact factor: 5.923

8.  Microstructural abnormalities in callosal fibers and their relationship with cognitive function in schizophrenia: A tract-specific analysis study.

Authors:  Yuji Ohoshi; Shun Takahashi; Shinichi Yamada; Takuya Ishida; Kumi Tsuda; Tomikimi Tsuji; Masaki Terada; Kazuhiro Shinosaki; Satoshi Ukai
Journal:  Brain Behav       Date:  2019-07-08       Impact factor: 2.708

Review 9.  Verbal memory measurement towards digital perspectives in first-episode psychosis: A review.

Authors:  Can Mişel Kilciksiz; Richard Keefe; James Benoit; Dost Öngür; John Torous
Journal:  Schizophr Res Cogn       Date:  2020-04-15

10.  Brain morphological and functional features in cognitive subgroups of schizophrenia.

Authors:  Yuka Yasuda; Naohiro Okada; Kiyotaka Nemoto; Masaki Fukunaga; Hidenaga Yamamori; Kazutaka Ohi; Daisuke Koshiyama; Noriko Kudo; Tomoko Shiino; Susumu Morita; Kentaro Morita; Hirotsugu Azechi; Michiko Fujimoto; Kenichiro Miura; Yoshiyuki Watanabe; Kiyoto Kasai; Ryota Hashimoto
Journal:  Psychiatry Clin Neurosci       Date:  2019-12-27       Impact factor: 5.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.